ILUMYA® helps most adult patients achieve clear or almost clear skin in as little as 12 weeks.
And 5 years into treatment, ILUMYA® is still going strong.
The most common (≥1%) adverse reactions for ILUMYA® compared to placebo are upper respiratory infections (14% vs 12%), injection site reactions (3% vs 2%), and diarrhea (2% vs 1%). See Important Safety Information below.
After my second dose of ILUMYA®, I didn't see any plaques and I wasn't always itching.
Individual results may vary.
Holly C., 43
Started ILUMYA® in June 2020
ILUMYA® COPAY PROGRAM
With the ILUMYA® Copay Card, eligible patients with commercial insurance may pay no more than $5* per dose. If you do not qualify for the copay card, there are still savings options available to you.
*Eligible commercially insured patients 18 years or older may pay as little as $5 per dose for an ILUMYA® prescription, subject to a $16,000 maximum annual program benefit. After the program maximum, patients will be responsible for the difference. This offer is valid only for patients who meet the program eligibility requirements, have commercial insurance that covers ILUMYA®, and have a valid prescription. One digital card per patient, not transferable, and cannot be combined with any other offer.
Discover a collection of tips and tricks from people just like you who have found ways to live more comfortably with their symptoms.
Topics include:
COMPLETE THE FORM BELOW TO GET YOUR FREE COPY!
By clicking the Submit button, I authorize Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents to contact me by mail, email, text message, or phone call (which may be made using an automated dialing system or an artificial or pre-recorded voice) to provide information on dermatology products, programs, services, and disease-state information and/or utilize my information for market research or analytics. Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute my personal information outside the above terms of consent.
Please refer to our Privacy Policy for more information.
What is the most important information I should know about ILUMYA® (tildrakizumab-asmn)?
Do not use ILUMYA if you have had a severe allergic reaction to ILUMYA or any of its ingredients.
Get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
ILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).
ILUMYA is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with ILUMYA and may treat you for TB before you begin treatment with ILUMYA if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with ILUMYA.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
Before receiving ILUMYA, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
It is not known if ILUMYA is safe and effective in children under 18 years of age.
What are the possible side effects of ILUMYA?
ILUMYA may cause serious side effects. See “What is the most important information I should know about ILUMYA?”
The most common side effects of ILUMYA include: upper respiratory infections, injection site reactions and diarrhea. These are not all of the possible side effects of ILUMYA. Call your doctor for medical advice about side effects.
You are encouraged to report any negative side effects of ILUMYA to FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or drug.safetyUSA@sunpharma.com (preferred) with as much information as available.
Please read the full Prescribing Information and Medication Guide for ILUMYA and discuss any questions with your doctor.
Get your free copy of the Psoriasis Hacks Guide: Ready, Set, PsO! It’s filled with great tips and life hacks from people like you who are living with moderate-to-severe plaque psoriasis.
By clicking the Submit button, I authorize Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents to contact me by mail, email, text message, or phone call (which may be made using an automated dialing system or an artificial or pre-recorded voice) to provide information on dermatology products, programs, services, and disease-state information and/or utilize my information for market research or analytics. Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute my personal information outside the above terms of consent.
Please refer to our Privacy Policy for more information.
